Bio-Equity 2025

Sebastien Stoitzner will be attending BioEquity

Bioequity 2025 GenSearch
We are pleased to announce that Sebastien Stoitzner will be attending BioEquity in Bruges this May. As a key figure in our organisation’s commitment to growth and innovation within the Life Sciences sector, Sebastien’s presence at this renowned conference underlines our dedication to staying at the forefront of industry developments.
Read more “Bio-Equity 2025”

Exploring the Future of Cell and Gene Therapies at Our HealthTech Leadership Dinner in Basel

We had the pleasure of co-hosting our #HealthTech Dinner in Basel with our partners at PwC Switzerland—an evening dedicated to exploring the evolving future of cell and gene therapies.

A heartfelt thank you to our guest speakers, Joshi Venugopal (Novartis Gene Therapies & Rare Diseases) and Gunther Busam (Orchard Therapeutics – U.S.), for their thought-provoking contributions.

Read more “Exploring the Future of Cell and Gene Therapies at Our HealthTech Leadership Dinner in Basel”

HealthTech Dinner – Basel

Heiko Bruhn
 Sule Erdim Ersoy from Novo Nordisk and Hans-Juergen Woerle Nestle

At the HealthTech Dinner last week, hosted by GenSearch and PwC Switzerland and, we gathered to explore one of today’s most impactful topics in healthcare: Transforming the future of obesity care.

The evening brought together brilliant minds in Pharma and Life Sciences, with insights shared by Sule Erdim Ersoy from Novo Nordisk and Hans-Juergen Woerle from Nestlé Health Science.

Read more “HealthTech Dinner – Basel”

HealthTech Dinner Paris 2024 – What Role for Start-up Studios?

Our 10th Parisian HealthTech Dinner took place on Tuesday 9th July 2024 and despite the competition from the France – Spain match, the room was full yet again!

Everyone had a wonderful evening in Paris, with our 3 speakers Pierre-Albert Colcomb from Ampleia, Clément Bertholet from AdBio partners and Stephane Tholander from Agora Health.

Read more “HealthTech Dinner Paris 2024 – What Role for Start-up Studios?”